Dr. Barry P Shapiro, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 7300 Van Dusen Rd, Laurel, MD 20707 Phone: 301-497-7954 |
Dr. Jeffrey J Hong, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 575 Main Street, Suite 351, Laurel, MD 20707 Phone: 301-498-5990 |
Peter Hammond, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 7300 Van Dusen Rd, Laurel, MD 20707 Phone: 301-497-7954 |
Puneet Chopra, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 13900 Baltimore Ave, Laurel, MD 20707 Phone: 301-725-5652 |
Dr. David M Weber, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3357b Corridor Marketplace, Laurel, MD 20724 Phone: 301-497-1820 |
Dr. Andrew Nicholson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 7300 Van Dusen Rd, Laurel, MD 20707 Phone: 301-725-4300 |
Dr. Carol Ann Nieroda, MD Emergency Medicine - Emergency Medical Services Medicare: Medicare Enrolled Practice Location: 7300 Van Dusen Rd, Emergency Room, Laurel, MD 20707 Phone: 301-497-7954 |
Arleen Allen, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 7300 Van Dusen Rd, Emergency Department, Laurel, MD 20707 Phone: 301-497-7954 |
Laura E. You, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3357b Corridor Marketplace, Laurel, MD 20724 Phone: 301-497-1820 |
Elias Lakew, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 7300 Van Dusen Rd, Laurel, MD 20707 Phone: 301-725-4300 |
Dr. Paul Bruce Baker, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 575 Main St, Suite 253, Laurel, MD 20707 Phone: 301-498-5990 |
News Archive
Medtronic of Canada Ltd. today announced the results of the first randomized, controlled trial comparing Kyphon Balloon Kyphoplasty with non-surgical care in treating spinal fractures in cancer patients.
Up to one third of women treated for breast cancer report fatigue symptoms up to 10 years after diagnosis, according to a new study.
Sangamo BioSciences, Inc. announced today the presentation of Phase 2 clinical data from its ZFP Therapeutic program to develop SB-509, a zinc finger protein transcriptional activator (ZFP-TF) of the vascular endothelial growth factor (VEGF)-A gene as a treatment for ALS.
In what is believed to be one of the largest studies of a rare disorder known as primary cutaneous gamma delta T-cell lymphoma, Rutgers Cancer Institute of New Jersey investigators and other collaborators examined characteristics, treatment patterns and outcomes of the disease, and determined accurate diagnosis of the disease requires ongoing analysis.
› Verified 4 days ago